Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines

References

• Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307 - 10; http://dx.doi.org/10.1038/35042675; PMID: 11099028
   PubMed Web of Science ®Google Scholar
• Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24:2899 - 908; http://dx.doi.org/10.1038/sj.onc.1208615; PMID: 15838523
   PubMed Web of Science ®Google Scholar
• Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev 2006; 20:236 - 52; http://dx.doi.org/10.1101/gad.1372606; PMID: 16418486
   PubMed Web of Science ®Google Scholar
• Sotgia F, Martinez-Outschoorn UE, Howell A, Pestell RG, Pavlides S, Lisanti MP. Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol 2012; 7:423 - 67; http://dx.doi.org/10.1146/annurev-pathol-011811-120856; PMID: 22077552
   PubMed Web of Science ®Google Scholar
• Cohen AW, Hnasko R, Schubert W, Lisanti MP. Role of caveolae and caveolins in health and disease. Physiol Rev 2004; 84:1341 - 79; http://dx.doi.org/10.1152/physrev.00046.2003; PMID: 15383654
   PubMed Web of Science ®Google Scholar
• Williams TM, Hassan GS, Li J, Cohen AW, Medina F, Frank PG, et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 2005; 280:25134 - 45; http://dx.doi.org/10.1074/jbc.M501186200; PMID: 15802273
   PubMed Web of Science ®Google Scholar
• Galbiati F, Volonté D, Liu J, Capozza F, Frank PG, Zhu L, et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001; 12:2229 - 44; PMID: 11514613
   PubMed Web of Science ®Google Scholar
• Palo AK, Sahu P, Choudhury RC. Etoposide-induced cytogenotoxicity in mouse spermatogonia and its potential transmission. J Appl Toxicol 2005; 25:94 - 100; http://dx.doi.org/10.1002/jat.1040; PMID: 15744785
   PubMed Web of Science ®Google Scholar
• Bartholomew JN, Volonte D, Galbiati F. Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway. Cancer Res 2009; 69:2878 - 86; http://dx.doi.org/10.1158/0008-5472.CAN-08-2857; PMID: 19318577
   PubMed Web of Science ®Google Scholar
• Bist A, Fielding CJ, Fielding PE. p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism. Biochemistry 2000; 39:1966 - 72; http://dx.doi.org/10.1021/bi991721h; PMID: 10684646
   PubMed Web of Science ®Google Scholar
• Shajahan AN, Wang A, Decker M, Minshall RD, Liu MC, Clarke R. Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity. J Biol Chem 2007; 282:5934 - 43; http://dx.doi.org/10.1074/jbc.M608857200; PMID: 17190831
   PubMed Web of Science ®Google Scholar
• Schlegel A, Schwab RB, Scherer PE, Lisanti MP. A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro. J Biol Chem 1999; 274:22660 - 7; http://dx.doi.org/10.1074/jbc.274.32.22660; PMID: 10428847
   PubMed Web of Science ®Google Scholar
• Sotgia F, Williams TM, Schubert W, Medina F, Minetti C, Pestell RG, et al. Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. Am J Pathol 2006; 168:292 - 309; http://dx.doi.org/10.2353/ajpath.2006.050429; PMID: 16400031
   PubMed Web of Science ®Google Scholar
• Li J, Hassan GS, Williams TM, Minetti C, Pestell RG, Tanowitz HB, et al. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle 2005; 4:1817 - 25; http://dx.doi.org/10.4161/cc.4.12.2199; PMID: 16294037
   PubMed Web of Science ®Google Scholar
• Razani B, Altschuler Y, Zhu L, Pestell RG, Mostov KE, Lisanti MP. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry 2000; 39:13916 - 24; http://dx.doi.org/10.1021/bi001489b; PMID: 11076533
   PubMed Web of Science ®Google Scholar
• Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC, Mellon JK. Caveolin-1 expression is associated with high-grade bladder cancer. Urology 2001; 58:811 - 4; http://dx.doi.org/10.1016/S0090-4295(01)01337-1; PMID: 11711373
   PubMed Web of Science ®Google Scholar
• Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Am J Clin Pathol 2003; 120:93 - 100; http://dx.doi.org/10.1309/292NHAYNWAVREJ37; PMID: 12866378
   PubMed Web of Science ®Google Scholar
• Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, et al. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 2002; 94:929 - 33; http://dx.doi.org/10.1002/cncr.10329; PMID: 11920460
   PubMed Web of Science ®Google Scholar
• Yang CP, Galbiati F, Volonte D, Horwitz SB, Lisanti MP. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett 1998; 439:368 - 72; http://dx.doi.org/10.1016/S0014-5793(98)01354-4; PMID: 9845355
   PubMed Web of Science ®Google Scholar
• Yang G, Truong LD, Wheeler TM, Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res 1999; 59:5719 - 23; PMID: 10582690
   PubMed Web of Science ®Google Scholar
• Lapshina MA, Parkhomenko II, Terentiev AA. Two forms of the nuclear matrix-bound p53 protein in HEK293 cells. Ann N Y Acad Sci 2006; 1090:177 - 81; http://dx.doi.org/10.1196/annals.1378.019; PMID: 17384260
   PubMed Web of Science ®Google Scholar
• Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits anoikis and promotes survival signaling in cancer cells. Adv Enzyme Regul 2006; 46:163 - 75; http://dx.doi.org/10.1016/j.advenzreg.2006.01.022; PMID: 16857240
   PubMedGoogle Scholar
• Ravid D, Maor S, Werner H, Liscovitch M. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene 2005; 24:1338 - 47; http://dx.doi.org/10.1038/sj.onc.1208337; PMID: 15592498
   PubMed Web of Science ®Google Scholar
• Wiebe JP, Lewis MJ. Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells. BMC Cancer 2003; 3:9; http://dx.doi.org/10.1186/1471-2407-3-9; PMID: 12659654
   PubMed Web of Science ®Google Scholar
• Anderson WA, Perotti ME, McManaway M, Lindsey S, Eckberg WR. Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes. J Submicrosc Cytol 1984; 16:673 - 90; PMID: 6438351
   PubMedGoogle Scholar
• Soto AM, Murai JT, Siiteri PK, Sonnenschein C. Control of cell proliferation: evidence for negative control on estrogen-sensitive T47D human breast cancer cells. Cancer Res 1986; 46:2271 - 5; PMID: 3697972
   PubMed Web of Science ®Google Scholar
• Xie D, Miller CW, O’Kelly J, Nakachi K, Sakashita A, Said JW, et al. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem 2001; 276:14187 - 94; PMID: 11297518
   PubMed Web of Science ®Google Scholar
• Hung KF, Lin SC, Liu CJ, Chang CS, Chang KW, Kao SY. The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med 2003; 32:461 - 7; http://dx.doi.org/10.1034/j.1600-0714.2003.00185.x; PMID: 12901727
   PubMed Web of Science ®Google Scholar
• Tanase CP, Dima S, Mihai M, Raducan E, Nicolescu MI, Albulescu L, et al. Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. J Mol Histol 2009; 40:23 - 9; http://dx.doi.org/10.1007/s10735-008-9209-7; PMID: 19160064
   PubMed Web of Science ®Google Scholar
• Bender FC, Reymond MA, Bron C, Quest AF. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 2000; 60:5870 - 8; PMID: 11059785
   PubMed Web of Science ®Google Scholar
• Glait C, Tencer L, Ravid D, Sarfstein R, Liscovitch M, Werner H. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways. Exp Cell Res 2006; 312:3899 - 908; http://dx.doi.org/10.1016/j.yexcr.2006.08.016; PMID: 17014845
   PubMed Web of Science ®Google Scholar
• Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 2005; 288:C494 - 506; http://dx.doi.org/10.1152/ajpcell.00458.2004; PMID: 15692148
   PubMed Web of Science ®Google Scholar
• Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55:5187 - 90; PMID: 7585571
   PubMed Web of Science ®Google Scholar
• Lee YS, Marks AR, Gureckas N, Lacro R, Nadal-Ginard B, Kim DH. Purification, characterization, and molecular cloning of a 60-kDa phosphoprotein in rabbit skeletal sarcoplasmic reticulum which is an isoform of phosphoglucomutase. J Biol Chem 1992; 267:21080 - 8; PMID: 1328221
   PubMed Web of Science ®Google Scholar
• Sherif ZA, Nakai S, Pirollo KF, Rait A, Chang EH. Downmodulation of bFGF-binding protein expression following restoration of p53 function. Cancer Gene Ther 2001; 8:771 - 82; http://dx.doi.org/10.1038/sj.cgt.7700361; PMID: 11687900
   PubMed Web of Science ®Google Scholar
• Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30:e15; http://dx.doi.org/10.1093/nar/30.4.e15; PMID: 11842121
   PubMed Web of Science ®Google Scholar
• Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990; 348:747 - 9; http://dx.doi.org/10.1038/348747a0; PMID: 2259385
   PubMed Web of Science ®Google Scholar